ranibizumab
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
Summary
ranibizumab is a type of chemical entity[1]. ranibizumab ranks in the top 6% of type of chemical entity entities by monthly Wikipedia readership (498 views/month).[2]
Key Facts
- Chemical formula: C₂₁₅₈H₃₂₈₂N₅₆₂O₆₈₁S₁₂[3]
- Subclass of: chemical compound[4]
- Has use: medication[5]
- Commons category: Ranibizumab[6]
- Has part(s): carbon[7]
- Route of administration: intravitreal administration[8]
- Has characteristic: biopharmaceutical[9]
- Medical condition treated: diabetic retinopathy[10], retinal disease[11], Kuhnt-Junius degeneration[12], cystoid macular edema[13], retinal vein occlusion[14], exudative vitreoretinopathy 1[15], macular retinal edema[16], eye disease[17], glaucoma[18]
- World Health Organisation international non-proprietary name: ranibizumab[19]
- Subject has role: angiogenesis inhibitor[20], monoclonal antibody[21]
- Pregnancy category: US pregnancy category C[22]
- Legal status (medicine): boxed warning[23]
- Active ingredient in: Lucentis[24]
Why It Matters
ranibizumab has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.[25] ranibizumab is known by 17 alternative names across languages and contexts.[26]